Influenza Virus Rapid Antigen Test Kit Market Research Report from 2024 forecast to 2030, by Manufacturers, Regions, Type and Application

The global Influenza Virus Rapid Antigen Test Kit market size was valued at USD 218 million in 2023 and is forecast to a readjusted size of USD 294 million by 2030 with a CAGR of 4.2% during review period. 

The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.

This report is a detailed and comprehensive analysis for global Influenza Virus Rapid Antigen Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Influenza Virus Rapid Antigen Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza Virus Rapid Antigen Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Influenza Virus Rapid Antigen Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

   BD
   Abbott
   Quidel
   Roche
   Actim
   Denka
   Guangzhou Wondfo Biotech
   Jiangsu Bioperfectus Technologies
   Hangzhou Biotest Biotech
   Wantai BioPharm
   Daan Gene

   Conventional RIDT
   Digital RIDT

   Hospital
   POCT
   Others

North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Influenza Virus Rapid Antigen Test Kit Market in 2025?

The strengths include quick results, ease of use, and increased demand due to rising influenza cases. These tests provide rapid detection and are crucial in managing outbreaks effectively, especially in remote or underserved areas. The adoption in both healthcare and at-home settings adds to the market's growth potential.

What are the weaknesses of the market in 2025?

The main weaknesses include accuracy concerns, as antigen tests may produce false negatives compared to PCR tests. Additionally, there are regulatory hurdles and varying standards across different regions, which can limit the widespread adoption of certain test kits.

What opportunities exist for the Influenza Virus Rapid Antigen Test Kit Market in 2025?

Opportunities lie in the increasing awareness of respiratory diseases and the growing preference for rapid diagnostics. There's potential for expansion into emerging markets where healthcare access is limited. Partnerships with healthcare providers and tech companies to integrate testing with digital platforms could also drive future growth.

What threats could impact the market in 2025?

The biggest threats are the development of more accurate diagnostic tools, such as advanced molecular tests, and potential regulatory changes that could affect test approval processes. Additionally, a decrease in influenza cases due to effective vaccination campaigns could reduce demand.

What are the political factors affecting the Influenza Virus Rapid Antigen Test Kit Market in 2025?

Political factors include government regulations on the approval and distribution of diagnostic tools. Changes in healthcare policies, such as increased funding for public health initiatives or pandemic preparedness, could influence market demand. Political stability in key markets will also affect the speed of adoption.

How do economic factors influence the market in 2025?

Economic factors include the affordability of these test kits, especially in developing regions. Economic downturns or recessions could impact healthcare budgets, leading to reduced access to testing. However, an increasing preference for low-cost, rapid diagnostics can stimulate market growth in cost-sensitive regions.

What are the social factors influencing the market in 2025?

Social factors include the growing awareness of influenza and the importance of quick testing in managing health crises. Increased public health education and a shift towards self-testing at home are likely to expand the market. Social attitudes towards health and hygiene also drive the adoption of rapid antigen tests.

How do technological factors impact the Influenza Virus Rapid Antigen Test Kit Market?

Technological advancements in diagnostic tools improve the accuracy and speed of antigen tests, driving their demand. The integration of these tests with digital health platforms for remote monitoring and data analysis offers opportunities for market growth. However, the rapid development of alternative technologies, such as PCR-based tests, could pose competition.

What environmental factors affect the market?

Environmental factors include the influence of climate change on the prevalence of influenza and other respiratory diseases. The seasonality of influenza outbreaks, particularly in colder months, will impact test kit sales. Sustainable manufacturing practices and the environmental impact of disposable medical products are becoming more important to consumers.

What legal factors impact the market in 2025?

Legal factors include compliance with health and safety regulations, intellectual property rights for new testing technologies, and data privacy concerns when using digital tools for testing. Variations in legal frameworks across countries may affect the speed at which these test kits can enter new markets.

Who are the suppliers in the Influenza Virus Rapid Antigen Test Kit Market in 2025?

Suppliers include manufacturers of raw materials, such as antibodies, antigens, and diagnostic reagents. Equipment suppliers for production lines and distributors of medical devices also play a crucial role in ensuring a smooth supply chain for test kit production.

What inputs are required in the market?

Key inputs include high-quality reagents, lab equipment, skilled labor for testing, and regulatory approvals. Additionally, investment in research and development for improving test accuracy and expanding testing capabilities is vital for market growth.

Who are the process owners in the market?

Process owners include manufacturers, healthcare providers, and regulatory bodies. Manufacturers oversee the production process, ensuring quality control, while healthcare providers facilitate the testing and diagnosis. Regulatory bodies ensure the products meet necessary health and safety standards.

What outputs are generated by the market?

Outputs consist of rapid antigen test kits, diagnostic results, and healthcare data for decision-making. These results are typically delivered to healthcare professionals or directly to consumers through home testing kits, facilitating quick diagnosis and treatment plans.

Who are the customers in the Influenza Virus Rapid Antigen Test Kit Market?

Customers include healthcare providers, hospitals, clinics, public health organizations, and individual consumers. Government bodies and global health organizations also play a role in purchasing large volumes for widespread distribution, especially during flu seasons or outbreaks.

What is the threat of new entrants in the Influenza Virus Rapid Antigen Test Kit Market in 2025?

The threat of new entrants is moderate. While the market has high demand, the barriers to entry, such as regulatory approval, significant capital investment, and technical expertise required for manufacturing, can deter new players. Established companies with strong reputations in diagnostics dominate the market.

How strong is the bargaining power of suppliers in this market?

The bargaining power of suppliers is moderate to high. Key suppliers of raw materials like reagents and diagnostic components have significant influence, as they provide the essential inputs for test kits. However, multiple suppliers exist, which provides some leverage to test kit manufacturers in terms of pricing.

What is the bargaining power of buyers in the market?

The bargaining power of buyers is moderate. Healthcare providers and government organizations are large buyers, but their power is somewhat limited by the specialized nature of rapid antigen tests. However, the growing number of options and increased competition in the market gives buyers some leverage, especially in price-sensitive regions.

How intense is the threat of substitute products?

The threat of substitutes is moderate to high. The market faces competition from other diagnostic methods, such as PCR-based tests and home test kits for other conditions. However, rapid antigen tests remain favored for their speed and convenience, making substitutes less attractive for those seeking quick results.

How competitive is the Influenza Virus Rapid Antigen Test Kit Market?

The market is highly competitive. Numerous established players, along with new entrants, compete to capture market share. Competition is driven by factors like price, accuracy, ease of use, regulatory approvals, and distribution networks. The demand for rapid diagnostics further fuels intense competition.

What are the key suppliers involved in the upstream activities of the Influenza Virus Rapid Antigen Test Kit Market?

Key suppliers include manufacturers of raw materials like antibodies, antigens, enzymes, and diagnostic reagents. Additionally, suppliers of diagnostic equipment, packaging materials, and labeling services play a role in supporting the production of test kits.

What are the raw materials and resources needed for the production of these test kits?

The main raw materials include monoclonal and polyclonal antibodies, antigens specific to influenza strains, reagents for testing, and specialized materials for packaging and labeling. Additionally, regulatory compliance resources, such as testing standards and certifications, are crucial in the upstream process.

How do regulatory requirements impact the upstream activities of this market?

Regulatory requirements significantly impact upstream activities, as manufacturers must comply with strict standards set by health authorities such as the FDA or EMA. Obtaining approvals and certifications for the raw materials and finished products is time-consuming and can influence supply chain timelines and costs.

What challenges are faced in the upstream supply chain of the Influenza Virus Rapid Antigen Test Kit Market?

Challenges include the volatility in the supply of key raw materials, regulatory delays, and the need for continuous innovation to improve test accuracy. Additionally, fluctuations in global trade or logistics disruptions can impact the timely availability of components, leading to production delays.

How do technological advancements influence upstream processes in the market?

Technological advancements in biotechnology, diagnostics, and manufacturing processes help improve the quality, efficiency, and cost-effectiveness of raw material production. These advancements enable better integration of components and faster scaling of production, which benefits overall market growth.

What are the key processes involved in the midstream activities of the Influenza Virus Rapid Antigen Test Kit Market?

Key processes include the assembly, packaging, and quality control of the test kits. These processes ensure that each kit meets regulatory standards and is ready for distribution. Manufacturers also handle logistics and coordinate with distributors to ensure timely availability of products to end customers.

How does the production process affect the midstream activities of the market?

The production process is critical to the efficiency of midstream activities. The quality of manufacturing directly influences the reliability and performance of the test kits, affecting distribution timelines. Efficient production and packaging minimize delays, ensuring that the test kits reach healthcare providers and consumers quickly.

What role do distributors play in the midstream activities of the market?

Distributors play a crucial role in bridging the gap between manufacturers and end users. They ensure that test kits are delivered to hospitals, clinics, pharmacies, and retail outlets. Distributors also handle inventory management and work with both regional and global supply chains to maintain a steady flow of products.

What challenges are faced during midstream activities in the market?

Challenges include logistical issues such as transportation delays, customs regulations, and fluctuating demand. Additionally, maintaining inventory levels to match seasonal flu peaks and managing the cold chain for certain test kits can create hurdles for distributors and manufacturers alike.

How do regulatory compliance and quality control affect midstream operations?

Regulatory compliance and quality control are essential to ensure that test kits meet safety and efficacy standards. Strict quality control measures are enforced at various stages of production and packaging, ensuring the kits are free of defects. This not only prevents recalls but also builds trust in the product during distribution.

Who are the key stakeholders in the downstream activities of the Influenza Virus Rapid Antigen Test Kit Market?

Key stakeholders include healthcare providers, such as hospitals, clinics, and pharmacies, who directly administer or sell the test kits. Additionally, individual consumers who use home testing kits and government health organizations responsible for distributing the kits during flu outbreaks are vital in the downstream process.

How does the distribution network affect the downstream activities?

The distribution network plays a crucial role in ensuring the timely availability of test kits to end users. Efficient distribution channels help ensure that test kits reach hospitals, clinics, and pharmacies on time, especially during peak flu seasons. Distribution strategies also affect pricing and accessibility in remote or underserved areas.

What are the challenges faced in the downstream activities of the market?

Challenges include delays in delivery due to supply chain disruptions, especially during flu seasons, and varying demand levels in different regions. Another issue is educating end users on the proper use of rapid antigen test kits to ensure accurate results. Regulatory changes and reimbursement policies can also impact downstream adoption.

How do consumers influence the downstream activities of the market?

Consumers drive demand for at-home testing kits, influencing manufacturers and distributors to scale up production and distribution. Consumer preferences for affordable and easy-to-use products push companies to innovate. Additionally, rising awareness about the importance of rapid diagnostics increases market penetration.

What impact do regulatory policies have on downstream operations?

Regulatory policies impact downstream operations by setting the standards for how test kits are marketed, distributed, and used. Changes in healthcare policies, reimbursement rates, and the approval process for over-the-counter tests can significantly affect market dynamics and the ease of access for end users.

Chapter 1, to describe Influenza Virus Rapid Antigen Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza Virus Rapid Antigen Test Kit, with price, sales quantity, revenue, and global market share of Influenza Virus Rapid Antigen Test Kit from 2019 to 2024.
Chapter 3, the Influenza Virus Rapid Antigen Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Virus Rapid Antigen Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Influenza Virus Rapid Antigen Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza Virus Rapid Antigen Test Kit.
Chapter 14 and 15, to describe Influenza Virus Rapid Antigen Test Kit sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Conventional RIDT
1.3.3 Digital RIDT
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 POCT
1.4.4 Others
1.5 Global Influenza Virus Rapid Antigen Test Kit Market Size & Forecast
1.5.1 Global Influenza Virus Rapid Antigen Test Kit Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity (2019-2030)
1.5.3 Global Influenza Virus Rapid Antigen Test Kit Average Price (2019-2030)

2 Manufacturers Profiles

2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Influenza Virus Rapid Antigen Test Kit Product and Services
2.1.4 BD Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments/Updates
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Influenza Virus Rapid Antigen Test Kit Product and Services
2.2.4 Abbott Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Recent Developments/Updates
2.3 Quidel
2.3.1 Quidel Details
2.3.2 Quidel Major Business
2.3.3 Quidel Influenza Virus Rapid Antigen Test Kit Product and Services
2.3.4 Quidel Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Quidel Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Influenza Virus Rapid Antigen Test Kit Product and Services
2.4.4 Roche Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Roche Recent Developments/Updates
2.5 Actim
2.5.1 Actim Details
2.5.2 Actim Major Business
2.5.3 Actim Influenza Virus Rapid Antigen Test Kit Product and Services
2.5.4 Actim Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Actim Recent Developments/Updates
2.6 Denka
2.6.1 Denka Details
2.6.2 Denka Major Business
2.6.3 Denka Influenza Virus Rapid Antigen Test Kit Product and Services
2.6.4 Denka Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Denka Recent Developments/Updates
2.7 Guangzhou Wondfo Biotech
2.7.1 Guangzhou Wondfo Biotech Details
2.7.2 Guangzhou Wondfo Biotech Major Business
2.7.3 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
2.7.4 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Guangzhou Wondfo Biotech Recent Developments/Updates
2.8 Jiangsu Bioperfectus Technologies
2.8.1 Jiangsu Bioperfectus Technologies Details
2.8.2 Jiangsu Bioperfectus Technologies Major Business
2.8.3 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product and Services
2.8.4 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Jiangsu Bioperfectus Technologies Recent Developments/Updates
2.9 Hangzhou Biotest Biotech
2.9.1 Hangzhou Biotest Biotech Details
2.9.2 Hangzhou Biotest Biotech Major Business
2.9.3 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
2.9.4 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hangzhou Biotest Biotech Recent Developments/Updates
2.10 Wantai BioPharm
2.10.1 Wantai BioPharm Details
2.10.2 Wantai BioPharm Major Business
2.10.3 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product and Services
2.10.4 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Wantai BioPharm Recent Developments/Updates
2.11 Daan Gene
2.11.1 Daan Gene Details
2.11.2 Daan Gene Major Business
2.11.3 Daan Gene Influenza Virus Rapid Antigen Test Kit Product and Services
2.11.4 Daan Gene Influenza Virus Rapid Antigen Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Daan Gene Recent Developments/Updates

3 Competitive Environment: Influenza Virus Rapid Antigen Test Kit by Manufacturer

3.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Manufacturer (2019-2024)
3.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Manufacturer (2019-2024)
3.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Influenza Virus Rapid Antigen Test Kit by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Influenza Virus Rapid Antigen Test Kit Manufacturer Market Share in 2023
3.4.3 Top 6 Influenza Virus Rapid Antigen Test Kit Manufacturer Market Share in 2023
3.5 Influenza Virus Rapid Antigen Test Kit Market: Overall Company Footprint Analysis
3.5.1 Influenza Virus Rapid Antigen Test Kit Market: Region Footprint
3.5.2 Influenza Virus Rapid Antigen Test Kit Market: Company Product Type Footprint
3.5.3 Influenza Virus Rapid Antigen Test Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Influenza Virus Rapid Antigen Test Kit Market Size by Region
4.1.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2030)
4.1.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2030)
4.1.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2019-2030)
4.2 North America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.3 Europe Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.4 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.5 South America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)
4.6 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030)

5 Market Segment by Type

5.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
5.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2019-2030)
5.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2030)

6 Market Segment by Application

6.1 Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
6.2 Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2019-2030)
6.3 Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2030)

7 North America

7.1 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
7.2 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
7.3 North America Influenza Virus Rapid Antigen Test Kit Market Size by Country
7.3.1 North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
7.3.2 North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

8.1 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
8.2 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
8.3 Europe Influenza Virus Rapid Antigen Test Kit Market Size by Country
8.3.1 Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
8.3.2 Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

9.1 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Market Size by Region
9.3.1 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

10.1 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
10.2 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
10.3 South America Influenza Virus Rapid Antigen Test Kit Market Size by Country
10.3.1 South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
10.3.2 South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

11.1 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Market Size by Country
11.3.1 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

12.1 Influenza Virus Rapid Antigen Test Kit Market Drivers
12.2 Influenza Virus Rapid Antigen Test Kit Market Restraints
12.3 Influenza Virus Rapid Antigen Test Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Influenza Virus Rapid Antigen Test Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza Virus Rapid Antigen Test Kit
13.3 Influenza Virus Rapid Antigen Test Kit Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza Virus Rapid Antigen Test Kit Typical Distributors
14.3 Influenza Virus Rapid Antigen Test Kit Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables

Table 1. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Influenza Virus Rapid Antigen Test Kit Product and Services
Table 6. BD Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. BD Recent Developments/Updates
Table 8. Abbott Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Major Business
Table 10. Abbott Influenza Virus Rapid Antigen Test Kit Product and Services
Table 11. Abbott Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Abbott Recent Developments/Updates
Table 13. Quidel Basic Information, Manufacturing Base and Competitors
Table 14. Quidel Major Business
Table 15. Quidel Influenza Virus Rapid Antigen Test Kit Product and Services
Table 16. Quidel Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Quidel Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Influenza Virus Rapid Antigen Test Kit Product and Services
Table 21. Roche Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Roche Recent Developments/Updates
Table 23. Actim Basic Information, Manufacturing Base and Competitors
Table 24. Actim Major Business
Table 25. Actim Influenza Virus Rapid Antigen Test Kit Product and Services
Table 26. Actim Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Actim Recent Developments/Updates
Table 28. Denka Basic Information, Manufacturing Base and Competitors
Table 29. Denka Major Business
Table 30. Denka Influenza Virus Rapid Antigen Test Kit Product and Services
Table 31. Denka Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Denka Recent Developments/Updates
Table 33. Guangzhou Wondfo Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Guangzhou Wondfo Biotech Major Business
Table 35. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
Table 36. Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Guangzhou Wondfo Biotech Recent Developments/Updates
Table 38. Jiangsu Bioperfectus Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Bioperfectus Technologies Major Business
Table 40. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product and Services
Table 41. Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Jiangsu Bioperfectus Technologies Recent Developments/Updates
Table 43. Hangzhou Biotest Biotech Basic Information, Manufacturing Base and Competitors
Table 44. Hangzhou Biotest Biotech Major Business
Table 45. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product and Services
Table 46. Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hangzhou Biotest Biotech Recent Developments/Updates
Table 48. Wantai BioPharm Basic Information, Manufacturing Base and Competitors
Table 49. Wantai BioPharm Major Business
Table 50. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product and Services
Table 51. Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Wantai BioPharm Recent Developments/Updates
Table 53. Daan Gene Basic Information, Manufacturing Base and Competitors
Table 54. Daan Gene Major Business
Table 55. Daan Gene Influenza Virus Rapid Antigen Test Kit Product and Services
Table 56. Daan Gene Influenza Virus Rapid Antigen Test Kit Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Daan Gene Recent Developments/Updates
Table 58. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Influenza Virus Rapid Antigen Test Kit Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Influenza Virus Rapid Antigen Test Kit Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Influenza Virus Rapid Antigen Test Kit, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 62. Head Office and Influenza Virus Rapid Antigen Test Kit Production Site of Key Manufacturer
Table 63. Influenza Virus Rapid Antigen Test Kit Market: Company Product Type Footprint
Table 64. Influenza Virus Rapid Antigen Test Kit Market: Company Product Application Footprint
Table 65. Influenza Virus Rapid Antigen Test Kit New Market Entrants and Barriers to Market Entry
Table 66. Influenza Virus Rapid Antigen Test Kit Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 68. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2024) & (K Units)
Table 69. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2025-2030) & (K Units)
Table 70. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2024) & (USD Million)
Table 71. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2025-2030) & (USD Million)
Table 72. Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2019-2024) & (US$/Unit)
Table 73. Global Influenza Virus Rapid Antigen Test Kit Average Price by Region (2025-2030) & (US$/Unit)
Table 74. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 75. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 76. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2024) & (US$/Unit)
Table 79. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2025-2030) & (US$/Unit)
Table 80. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 81. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 82. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2024) & (US$/Unit)
Table 85. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2025-2030) & (US$/Unit)
Table 86. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 87. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 88. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 89. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 90. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 91. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 92. North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 93. North America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 95. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 96. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 97. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 98. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 99. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 100. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 101. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 103. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 104. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 105. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 106. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2019-2024) & (K Units)
Table 107. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity by Region (2025-2030) & (K Units)
Table 108. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2019-2024) & (USD Million)
Table 109. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value by Region (2025-2030) & (USD Million)
Table 110. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 111. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 112. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 113. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 114. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 115. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 116. South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2019-2024) & (K Units)
Table 121. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Application (2025-2030) & (K Units)
Table 122. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2019-2024) & (K Units)
Table 123. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity by Country (2025-2030) & (K Units)
Table 124. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2019-2024) & (USD Million)
Table 125. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value by Country (2025-2030) & (USD Million)
Table 126. Influenza Virus Rapid Antigen Test Kit Raw Material
Table 127. Key Manufacturers of Influenza Virus Rapid Antigen Test Kit Raw Materials
Table 128. Influenza Virus Rapid Antigen Test Kit Typical Distributors
Table 129. Influenza Virus Rapid Antigen Test Kit Typical Customers

List of Figures

Figure 1. Influenza Virus Rapid Antigen Test Kit Picture
Figure 2. Global Influenza Virus Rapid Antigen Test Kit Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type in 2023
Figure 4. Conventional RIDT Examples
Figure 5. Digital RIDT Examples
Figure 6. Global Influenza Virus Rapid Antigen Test Kit Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application in 2023
Figure 8. Hospital Examples
Figure 9. POCT Examples
Figure 10. Others Examples
Figure 11. Global Influenza Virus Rapid Antigen Test Kit Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Influenza Virus Rapid Antigen Test Kit Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Influenza Virus Rapid Antigen Test Kit Price (2019-2030) & (US$/Unit)
Figure 15. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Influenza Virus Rapid Antigen Test Kit by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 18. Top 3 Influenza Virus Rapid Antigen Test Kit Manufacturer (Revenue) Market Share in 2023
Figure 19. Top 6 Influenza Virus Rapid Antigen Test Kit Manufacturer (Revenue) Market Share in 2023
Figure 20. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Influenza Virus Rapid Antigen Test Kit Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2019-2030)
Figure 32. Global Influenza Virus Rapid Antigen Test Kit Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 45. France Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Region (2019-2030)
Figure 53. China Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 54. Japan Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 55. South Korea Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 56. India Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 57. Southeast Asia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 58. Australia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 59. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 64. Argentina Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Sales Quantity Market Share by Country (2019-2030)
Figure 68. Middle East & Africa Influenza Virus Rapid Antigen Test Kit Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 70. Egypt Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 72. South Africa Influenza Virus Rapid Antigen Test Kit Consumption Value (2019-2030) & (USD Million)
Figure 73. Influenza Virus Rapid Antigen Test Kit Market Drivers
Figure 74. Influenza Virus Rapid Antigen Test Kit Market Restraints
Figure 75. Influenza Virus Rapid Antigen Test Kit Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Influenza Virus Rapid Antigen Test Kit in 2023
Figure 78. Manufacturing Process Analysis of Influenza Virus Rapid Antigen Test Kit
Figure 79. Influenza Virus Rapid Antigen Test Kit Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source